$100 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today

Biomarin Pharmaceutical (NASDAQ:BMRN) has outperformed the market over the past 20 years by 6.44% on an annualized basis producing an average annual return of 14.87%. Currently, Biomarin Pharmaceutical has a market capitalization of $16.09 billion.

Buying $100 In BMRN: If an investor had bought $100 of BMRN stock 20 years ago, it would be worth $1,718.66 today based on a price of $84.73 for BMRN at the time of writing.

Biomarin Pharmaceutical's Performance Over Last 20 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.